Ironwood Pharmaceuticals (IRWD) Capital Expenditures (2010 - 2025)
Ironwood Pharmaceuticals (IRWD) posted Capital Expenditures of -$1000.0 for Q4 2025, down 150.0% sequentially from $2000.0 in Q3 2025.
Ironwood Pharmaceuticals (IRWD) Capital Expenditures (2010 - 2025) Analysis & Trends
Ironwood Pharmaceuticals has reported Capital Expenditures for 16 years, with the latest figure at -$1000.0 in Q4 2025.
- Quarterly Capital Expenditures changed N/A year-over-year to -$1000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $34000.0 (down 76.06% YoY) and the FY2025 annual result came in at $34000.0, down 76.06% from the prior year.
- Capital Expenditures slipped to -$1000.0 in Q4 2025 per IRWD's latest filing, from $2000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $211000.0 in Q4 2023 and troughed at -$27000.0 in Q4 2022.
- A 5-year average of $47533.3 and a median of $31000.0 in 2025 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures tumbled 121.09% in 2022, then jumped 881.48% in 2023.
- Over 5 years, Capital Expenditures stood at $128000.0 in 2021, then sank by 121.09% to -$27000.0 in 2022, then surged by 881.48% to $211000.0 in 2023, then plunged by 92.42% to $16000.0 in 2024, then slumped by 106.25% to -$1000.0 in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$1000.0, $2000.0, and $2000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 706.94 Mn | 627.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Dec 31, 2023 | 211,000.00 |
| Dec 31, 2023 | 211,000.00 |
| Sep 30, 2023 | 49,000.00 |
| Sep 30, 2023 | 49,000.00 |
| Mar 31, 2023 | 13,000.00 |
| Mar 31, 2023 | 13,000.00 |